Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
Conditions of optimal recombinant Human LILRB2/CD85d/ILT4 Protein performance should be determined experimentally by the investigator.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
BP004941: Human LILRB2/CD85d/ILT4 Protein with the C-hFc Tag
Source: The recombinant Human LILRB2/CD85d/ILT4 Protein, (amino acids Gln22-His458) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Human LILRB2/CD85d/ILT4 protein with the hFc tag at the C-terminus has a predicted MW of 74.1 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Tris-Bis PAGE result.
Activity: Immobilized recombinant Human LILRB2 protein with the C-hFc tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Anti-LILRB2 Antibody protein with the C-hFc tag with the EC50 of 14.6 ng/ml determined by ELISA (QC Test). The affinity constant of 9.20 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human LILRB2/CD85d/ILT4 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.
BP004839: Human LILRB2/CD85d/ILT4 Protein with the C-mFc Tag
Source: The recombinant Human LILRB2/CD85d/ILT4 Protein, (amino acids Gln22-His458) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Human LILRB2/CD85d/ILT4 protein with the mFc tag at the C-terminus has a predicted MW of 73.6 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Tris-Bis PAGE result.
Activity: Immobilized recombinant Human LILRB2 protein with the C-mFc tag at 0.2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-LILRB2 Antibody protein with the C-hFc tag with the EC50 of 10.2 ng/ml determined by ELISA (QC Test).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human LILRB2/CD85d/ILT4 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.
BP005482: Human LILRB2/CD85d/ILT4 Protein with the C-His-Avi Tag
Source: The recombinant Human LILRB2/CD85d/ILT4 Protein, (amino acids Gln22-His458) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Human LILRB2/CD85d/ILT4 protein with the His-Avi tag at the C-terminus has a predicted MW of 50.2 kDa. Due to glycosylation, the protein migrates to 70-75 kDa based on Tris-Bis PAGE result.
Activity: Immobilized recombinant Human LILRB2 protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-LILRB2 Antibody protein with the C-hFc tag with the EC50 of 3.5 ng/ml determined by ELISA (QC Test).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human LILRB2/CD85d/ILT4 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.
Shipping: The recombinant Human LILRB2/CD85d/ILT4 Protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 week, 2 to 8°C under sterile conditions after reconstitution.
6 months, -20 to -70°C under sterile conditions after reconstitution.
Syd Labs provides the following LILRB2 Protein:
Biotinylated Human LILRB2 Protein
Cynomolgus LILRB2 Protein
Human LILRB2 Protein
Syd Labs provides the following LILRB Protein:
Biotinylated Human LILRB1 Protein
Biotinylated Human LILRB3 Protein
Biotinylated Human LILRB4 Protein
Biotinylated Human LILRB5 Protein
Cynomolgus LILRB1 Protein
Cynomolgus LILRB4 Protein
Human LILRB1 Protein
Human LILRB3 Protein
Human LILRB4 Protein
Human LILRB5 Protein
Mouse LILRB4 Protein
Human LILRB1/CD85j/ILT2 Protein with the C-His Tag
Rhesus macaque LILRB1 Protein
Copyright © 2009-2025 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.
Friend Link: Ushelf